Retraction Note to: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (Q99560673)
Jump to navigation
Jump to search
scientific article published on 17 September 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Retraction Note to: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study |
scientific article published on 17 September 2020 |
Statements
Retraction Note to: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study (English)
Milena Penkowa
1 reference
Per Boye Hansen
17 September 2020